Device / Technology News

RSS

ClearCount announces closing of $5 million Series B financing round

ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today the close of its $5M Series B financing round. The company will use the funds to drive market penetration and research and development of its RFID-based solutions for hospital patient safety applications. ClearCount has developed the first FDA-cleared sponge counting and detection solution.

31 Aug 2010

Project GreenVax to acquire XDR GMP single-use production bioreactors from Xcellerex

Xcellerex, Inc. announced today that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, Texas. Project GreenVax is spearheaded by Texas Plant-Expressed Vaccine Consortium, which consists of G-Con, LLC and The Texas A&M University System. Financial terms were not disclosed.

31 Aug 2010

First mind controlled prosthesis

Christian Kandlbauer, who lost both of his arms in a high voltage accident, uses a unique development which until recently sounded almost like science fiction: An arm prosthesis, the first of its kind in the world, which he controls solely through the power of his mind.

31 Aug 2010

Sonomax and Solar Ear Brazil sign Term Sheet to develop hearing aids

Sonomax Technologies Inc. is pleased to announce that it has signed a Term Sheet with Brazil based Solar Ear. Under the terms of the agreement, Sonomax will adapt it's V4 earmold so that it can be paired with Solar Ear's BTE (Behind-the-ear) hearing aids and supported by Solar Ear's unique solar chargers. The hearing aids resulting from the marriage of these leading edge technologies will be for distribution throughout the developing world.

31 Aug 2010

GE Healthcare uses Eurotech TurboXb computer on module in EView ventilator data capture device

Eurotech, a leading supplier of embedded technologies, products, and systems and a strategic supplier to GE Healthcare, today announces the Eurotech TurboXb computer on module has been deployed in GE Healthcare's EView ventilator data capture device, in accordance with the contract announced on Nov 12, 2009.

31 Aug 2010

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

Oxygen Biotherapeutics, Inc. today announced that results from an 8-week cosmetic study showed that the topical application of DERMACYTE Oxygen Concentrate, an oxygen-rich skin care lotion, appears to improve the appearance of fine lines and the perception of skin appearance.

31 Aug 2010

CPA and Nightingale launch interactive Personal Health Record portal

Canadian Patient Access Inc. and Nightingale Informatix Corporation today announce the launch of myPatientAccess.ca, Canada's first interactive patient portal to be fully integrated with an electronic medical records (EMR) system. A breakthrough offering in consumer healthcare, Canadian patients will, for the first time, have full, web-based, real-time access to their Personal Health Record (PHR), with information that has been validated by their physician.

31 Aug 2010

TearLab and AMO Canada enter cooperative marketing agreement

TearLab Corporation today announced that it has entered into a cooperative marketing agreement with Abbott Medical Optics Inc.'s subsidiary, AMO Canada Company. Under the agreement, AMO Canada's sales force will directly sell the TearLab™ Osmolarity System in Canada while TearLab will help promote AMO Canada's products for the relief of dry eye symptoms, including Blink® Moisturizing Eye Drops. Financial terms were not disclosed.

31 Aug 2010

Recommendations for revascularisation in coronary artery disease patients

There have been several studies into the impact of completeness of revascularisation in recent years, yet few clear recommendations are available on the likely clinical outcomes. This topic is not formally addressed in either the European Society of Cardiology guidelines or those jointly issued by the American Heart Association and American College of Cardiology.

31 Aug 2010

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".

31 Aug 2010

EDIMS licenses First DataBank's National Drug Data File Plus database

First DataBank, a leading provider of drug databases that help drive patient safety, and EDIMS, a leading provider of interoperable emergency department (ED) information management systems, today announced they have licensed First DataBank's National Drug Data File (NDDF) Plus™ database to offer hospitals greater choice in trusted third-party drug database information to use and integrate with EDIMS ED electronic health record (EHR).

31 Aug 2010

DePuy Orthopaedics sued over faulty hip-implant devices

Hip-implant surgery is commonplace, but a higher than expected number of failures began to surface in patients who had received an implanted device manufactured by a division of J&J. According to company statistics, about one in eight implant patients requires a painful and expensive second procedure called a "revision surgery."

31 Aug 2010

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 7 million people in Europe. It is a progressive chronic disease in which episodes become more frequent and long-lasting over time. Conventional anti-arrhythmic therapy aims at halting progression and reducing symptoms, but the use of most anti-arrhythmic drugs is compromised by severe side effects, such as pro-arrhythmia or extra-cardiac organ toxicity.

31 Aug 2010

OrthoAccel announces full-market release of AcceleDent dental device

OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.

31 Aug 2010

InSightec's ExAblate Robotic Acoustic Surgery system used for prostate cancer treatment

InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.

31 Aug 2010

Dedicated web site for PKU medical education to be launched at 2010 SSIEM Annual Symposium

PKU specialists around the world can now count on a brand-new, authoritative website entirely dedicated to this rare genetic disorder, which affects one out of every 10,000 to 20,000 live births worldwide.

31 Aug 2010

MGH scientists develop new microfluidic tool for accurate isolation of neutrophils

A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.

31 Aug 2010

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.

31 Aug 2010

Detroit Medical Center's system-wide EMR helps save over $5 million in costs

The Detroit Medical Center (DMC) achieved significant improvements in patient safety and quality of care, while also saving more than $5 million in costs last year, thanks to efficiencies created by its system-wide Electronic Medical Record (EMR). This system manages nearly all of the DMC's patient health information via new computer-based technology.

31 Aug 2010

African-Americans at higher risk of developing stent thrombosis

African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.

31 Aug 2010

Device / Technology News

ClearCount announces closing of $5 million Series B financing round

Project GreenVax to acquire XDR GMP single-use production bioreactors from Xcellerex

First mind controlled prosthesis

Sonomax and Solar Ear Brazil sign Term Sheet to develop hearing aids

GE Healthcare uses Eurotech TurboXb computer on module in EView ventilator data capture device

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

CPA and Nightingale launch interactive Personal Health Record portal

TearLab and AMO Canada enter cooperative marketing agreement

Recommendations for revascularisation in coronary artery disease patients

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

EDIMS licenses First DataBank's National Drug Data File Plus database

DePuy Orthopaedics sued over faulty hip-implant devices

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

OrthoAccel announces full-market release of AcceleDent dental device

InSightec's ExAblate Robotic Acoustic Surgery system used for prostate cancer treatment

Dedicated web site for PKU medical education to be launched at 2010 SSIEM Annual Symposium

MGH scientists develop new microfluidic tool for accurate isolation of neutrophils

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

Detroit Medical Center's system-wide EMR helps save over $5 million in costs

African-Americans at higher risk of developing stent thrombosis

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News